Clinical Trial Update: A Post Market Study to Assess the Spinal Modulation Neurostimulator System for Chronic Intractable Pain

View source ↗

Summary

Results of a post-market study evaluating Abbott's spinal modulation neurostimulator system for chronic intractable pain have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pain

Snippet

Sponsor: Abbott Medical Devices | Conditions: Chronic Pain | Status: COMPLETED | Results posted: 2017-08-03